Thioredoxin-interacting protein, hematopoietic stem cells, and hematopoiesis

Current Opinion in Hematology

Volumn 21, Issue 4, 2014, Pages 265-270

  Jung, Haiyoung ^a,b   Choi, Inpyo ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

Hematopoiesis; Hematopoietic stem cells; Reactive oxygen species; Thioredoxin; Thioredoxin interacting protein

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; THIOREDOXIN; THIOREDOXIN INTERACTING PROTEIN; CARRIER PROTEIN; TXNIP PROTEIN, HUMAN;

APOPTOSIS; CELL DIFFERENTIATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; ANIMAL; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CARRIER PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; OXIDATIVE STRESS;

EID: 84902239929     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000037     Document Type: Review

References (68)

1. Das KC. Thioredoxin and its role in premature newborn biology. Antioxid Redox Signal 2005; 7:1740-1743.
2. Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 2005; 7:823-828.
3. Chen KS, DeLuca HF. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta 1994; 1219:26-32.
4. Junn E, Han SH, Im JY, et al. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000; 164:6287-6295.
5. Kaimul AM, Nakamura H, Masutani H, Yodoi J. Thioredoxin and thioredoxinbinding protein-2 in cancer and metabolic syndrome. Free Radic Biol Med 2007; 43:861-868.
6. Polekhina G, Ascher DB, Kok SF, et al. Structure of the N-terminal domain of human thioredoxin-interacting protein. Acta Crystallogr D Biol Crystallogr 2013; 69:333-344.
7. Eliades A, Matsuura S, Ravid K. Oxidases and reactive oxygen species during hematopoiesis: a focus on megakaryocytes. J Cell Physiol 2012; 227:3355-3362.
8. Urao N, Ushio-Fukai M. Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic Biol Med 2013; 54:26-39.
9. Friedman JS, Rebel VI, Derby R, et al. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med 2001; 193:925-934.
10. Kong Y, Zhou S, Kihm AJ, et al. Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. J Clin Invest 2004; 114:1457-1466.
11. Neumann CA, Krause DS, Carman CV, et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003; 424:561-565.
12. Piao ZH, Kim MS, Jeong M, et al. VDUP1 exacerbates bacteremic shock in mice infected with Pseudomonas aeruginosa. Cell Immunol 2012; 280:1-9.
13. Jung H, Kim MJ, Kim DO, et al. TXNIP maintains the hematopoietic cell pool by switching the function of p53 under oxidative stress. Cell Metab 2013; 18:75-85.
14. Park YJ, Yoon SJ, Suh HW, et al. TXNIP deficiency exacerbates endotoxic shock via the induction of excessive nitric oxide synthesis. PLoS Pathog 2013; 9:e1003646.
15. Ludwig DL, Kotanides H, Le T, et al. Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene. Gene 2001; 269:103-112.
16. Zhou J, Yu Q, Chng WJ. TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms. Int J Biochem Cell Biol 2011; 43:1668-1673.
17. Jeong M, Piao ZH, Kim MS, et al. Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions. J Immunol 2009; 183:2495-2505.
18. Kwon HJ, Won YS, Yoon YD, et al. Vitamin D3 up-regulated protein 1 deficiency accelerates liver regeneration after partial hepatectomy in mice. J Hepatol 2011; 54:1168-1176.
19. Patwari P, Higgins LJ, Chutkow WA, et al. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 2006; 281:21884-21891.
20. Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999; 274:21645-21650.
21. Zhang P, Wang C, Gao K, et al. The ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradation. J Biol Chem 2010; 285:8869-8879.
22. Butler LM, Zhou X, Xu WS, et al. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA 2002; 99:11700-11705.
23. Takahashi Y, Nagata T, Ishii Y, et al. Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620. Oncol Rep 2002; 9:75-79.
24. Nishinaka Y, Nishiyama A, Masutani H, et al. Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res 2004; 64:1287-1292.
25. Dutta KK, Nishinaka Y, Masutani H, et al. Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis. Lab Invest 2005; 85:798-807.
26. Jeon JH, Lee KN, Hwang CY, et al. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res 2005; 65:4485-4489.
27. Lee KN, Kang HS, Jeon JH, et al. VDUP1 is required for the development of natural killer cells. Immunity 2005; 22:195-208.
28. Shin D, Jeon JH, Jeong M, et al. VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway. Biochim Biophys Acta 2008; 1783:838-848.
29. Kwon HJ, Won YS, Suh HW, et al. Vitamin D3 upregulated protein 1 suppresses TNF-alpha-induced NF-kappaB activation in hepatocarcinogenesis. J Immunol 2010; 185:3980-3989.
30. Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11:136-140.
31. Ogata FT, Batista WL, Sartori A, et al. Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization. PLoS One 2013; 8:e84588.
32. Hwang J, Suh HW, Jeon YH, et al. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Nat Commun 2014; 5:2958.
33. Kondo N, Nakamura H, Masutani H, Yodoi J. Redox regulation of human thioredoxin network. Antioxid Redox Signal 2006; 8:1881-1890.
34. Spindel ON, World C, Berk BC. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid Redox Signal 2012; 16:587-596.
35. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001; 31:1287-1312.
36. Schulze PC, De Keulenaer GW, Yoshioka J, et al. Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res 2002; 91:689-695.
37. Nakamura H, De Rosa S, Roederer M, et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 1996; 8:603-611.
38. Yamawaki H, Pan S, Lee RT, Berk BC. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 2005; 115:733-738.
39. Wang Y, De Keulenaer GW, Lee RT. Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 2002; 277:26496-26500.
40. Yu FX, Goh SR, Dai RP, Luo Y. Adenosine-containing molecules amplify glucose signaling and enhance txnip expression. Mol Endocrinol 2009; 23:932-942.
41. Zitman-Gal T, Green J, Pasmanik-Chor M, et al. Endothelial pro-atherosclerotic response to extracellular diabetic-like environment: possible role of thioredoxininteracting protein. Nephrol Dial Transplant 2010; 25:2141-2149.
42. Shah A, Xia L, Goldberg H, et al. Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J Biol Chem 2013; 288:6835-6848.
43. World C, Spindel ON, Berk BC. Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-alpha: a key mechanism for vascular endothelial growth factor receptor- 2 transactivation by reactive oxygen species. Arterioscler Thromb Vasc Biol 2011; 31:1890-1897.
44. Xiang G, Seki T, Schuster MD, et al. Catalytic degradation of vitamin D upregulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem 2005; 280:39394-39402.
45. Yu Y, Xing K, Badamas R, et al. Overexpression of thioredoxin-binding protein 2 increases oxidation sensitivity and apoptosis in human lens epithelial cells. Free Radic Biol Med 2013; 57:92-104.
46. Kim SY, Suh HW, Chung JW, et al. Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases. Cell Mol Immunol 2007; 4:345-351.
47. Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med 2014; 66:75-87.
48. Miyamoto K, Araki KY, Naka K, et al. FOXO3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007; 1:101-112.
49. Tothova Z, Kollipara R, Huntly BJ, et al. FOXOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007; 128:325-339.
50. Yalcin S, Zhang X, Luciano JP, et al. FOXO3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem 2008; 283:25692-25705.
51. Arai F, Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007; 1106:41-53.
52. Brunelle JK, Bell EL, Quesada NM, et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1:409-414.
53. Guzy RD, Hoyos B, Robin E, et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 2005; 1:401-408.
54. Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal 2008; 10:1923-1940.
55. Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011; 9:298-310.
56. Ito K, Hirao A, Arai F, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004; 431:997-1002.
57. Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 2006; 12:446-451.
58. Li X, Erden O, Li L, et al. Binding to WGR domain by salidroside activates PARP1 and protects hematopoietic stem cells from oxidative stress. Antioxid Redox Signal 2013. [Epub ahead of print]
59. Nakamura S, Oshima M, Yuan J, et al. BMI1 confers resistance to oxidative stress on hematopoietic stem cells. PLoS One 2012; 7:e36209.
60. Unnisa Z, Clark JP, Roychoudhury J, et al. MEIS1 preserves hematopoietic stem cells in mice by limiting oxidative stress. Blood 2012; 120:4973-4981.
61. Tai-Nagara I, Matsuoka S, Ariga H, Suda T. Mortalin and DJ-1 coordinately regulate hematopoietic stem cell function through the control of oxidative stress. Blood 2014; 123:41-50.
62. Povinelli BJ, Nemeth MJ. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells 2014; 32:105-115.
63. Sattler M, Winkler T, Verma S, et al. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 1999; 93:2928-2935.
64. Sardina JL, Lopez-Ruano G, Sanchez-Sanchez B, et al. Reactive oxygen species: are they important for haematopoiesis? Crit Rev Oncol Hematol 2012; 81:257-274.
65. OBrien JJ, Spinelli SL, Tober J, et al. 15-Deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes. Blood 2008; 112:4051-4060.
66. Hirose K, Monzen S, Sato H, et al. Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate. J Radiat Res 2013; 54:438-446.
67. Santos Franco S, De Falco L, Ghaffari S, et al. Resveratrol accelerates erythroid maturation by activation of FOXO3 and ameliorates anemia in beta-thalassemic mice. Haematologica 2014; 99:267-275.
68. Chung YJ, Robert C, Gough SM, et al. Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome. Leuk Res 2014; 38:95-102.